Stage IV Lung Cancer Comparative Analysis

I have access to a library of legally published, fully de-identified case materials on female patients diagnosed with Stage IV lung cancer and I’d like a methodologically solid comparative analysis carried out on them. All records are ready to share as soon as we agree on the sample size, so the very first thing I need from you is an estimate of how many individual cases you feel are necessary to answer the research questions with confidence.

Scope
• Core task: perform a rigorous comparative analysis across the selected cases.
• Focus population: women, Stage IV lung cancer.
• Data provenance: strictly de-identified materials drawn from peer-reviewed sources; I can also secure additional cases from hospital registries or clinical-trial publications if that would strengthen the dataset.

What I expect to receive
1. A brief plan confirming the analytic framework you will use once we lock the case count.
2. The completed comparative analysis presented in a clear narrative report, supplemented by tables, charts or other visual aids where useful.
3. A concise discussion of clinical implications and any limitations you identify in the source data.

We can prioritise treatment outcomes, survival rates, quality-of-life metrics—or a mix—depending on your expertise and the final data pool. Please outline your preferred statistical or qualitative tools, anticipated timelines, and, again, the case volume you recommend so we can get started right away.